The article Hawaii Passes Bill To Prepare For Federal Approval of Psychedelics was originally published on Microdose.
Psychedelic legislation is moving through the Aloha state.
The Hawaii Senate has approved a bill HB1340, a proposed law that would create an advisory board to explore and prepare for regulations around federal approval of “breakthrough therapies” like psychedelics.
The bill, originally sponsored by Rep. Adrian Tam (D), had already passed through the House and was in the Senate for possible amendments. The bill would require the state Department of Health (DOH) to establish a Breakthrough Therapy Designation Advisory Council.
As reported by Marijuana Moment, HB 1340 would:
- Create an advisory council, tasked with exploring state and federal regulations on certain psychedelics, in addition to reviewing scientific literature related to using them for mental health treatment.
- The council would need to assess FDA breakthrough therapies within three months of FDA giving the substance that designation.
- Members of the council would need to include the OWR director, state attorney general, law enforcement director, legislative leadership and a physician. Others could be appointed by top lawmakers and the OWR director.
- The body would need to examine the “requirements, specifications, and guidelines for a health care professional to prescribe and provide various treatments for patients who may benefit.”
The bill passed the Senate on Tuesday without much debate and heads back to the House for another, and perhaps final, vote.